toto

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/30

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

31 Terms

1
New cards

what is the ending for mouse mAB

omab

2
New cards

what is ending for chimeric mAB

ximab

3
New cards

what is ending for humanized mAB

zumab

4
New cards

what is ending for human mAB

umab

5
New cards

what factor of a mAB makes it more likely to elicit anti-therapeutic immune response

the more component of a mAB that is non-human

6
New cards

adv of nanobodies as therapeutics compared to mammalian Ig

one protein binding domain = easier manu

more stable = more resistant to pH and chemistry changes

7
New cards

disadv of nanobodies as therapeutics compared to mammalian Ig

low bioavailability = need modifications for efficacy

small = hard to work with

8
New cards

purpose of Fc region

HUMAN fc regions illicit immune response for antibody dependent cytotoxicity and complement dependent cytotoxicity

this part of the mAB interacts with NK cell

9
New cards

which mAB can bind to two different proteins

bi specific mAB

10
New cards

what are the benefits of a fragmant as a therapeutic

better at distributing to dense and poorly vascularized tissues = tumors

11
New cards

what terms are for patient’s own cells

autologos, autogenic

12
New cards

what terms are for therapeutics from other people’s cells

allogenic, heterologous

13
New cards

what factors limit CAR T cell therapeutics

need a specific target

off-target effects =cytokine toxicity/storm

14
New cards

what type of gene therapy reduces expression of mutated gene

gene silencing

15
New cards

what type of gene therapy fixes the mutated gene

genome editing

16
New cards

what type of gene therapy adds in a good copy of the gene

ectopic expression

17
New cards

pros and cons of gene silencing

pro: gets rid of overactive gene, SAFE = no risk of of-target effects

con: temporary and requires continuous therapy

18
New cards

pros and cons of genome editing

pro: fixes any problem

con: can lead to off target mutations

19
New cards

pros and cons of ectopic expression

pro: long term and generally safe

con: use of viral vectors can be limiting for some populations

20
New cards

what are the types of viruses for gene therapy

HSV-1

lentivirus

adeno-associated

21
New cards

which viral vectors are episomal

HSV-1

adeno-associated (occasional integrating)

22
New cards

which viral vectors are integrating vectors

lentivirus

23
New cards

what is an episomal vector and pros?

virus does not integrate into host genome

pro: used short term, lower risk of mutations

24
New cards

what is a integrating vector and pros?

vector embeds into host genome

pro: good long term, risk of mutations (cancer)

25
New cards

what is the FDA approved oncolytic therapeutic

imlygic (talimogene laherparepvec)

26
New cards

imglytic is used for

melanoma

27
New cards

what type of vector is used for imglytic

HSV-1

28
New cards

what is target of imglytic

GM-CSF

29
New cards

what are the reasons for a placebo in vaccine trial

if there is an established treatment = unethical to use inactive placebo

30
New cards

what vaccine type needs target antigens

viral vector

mRNA

protein subunit

31
New cards

which vaccines do not need specitific target antigens

whole inactivated

live attenuated